In our recent CAD meta-analysis of 122,733 CAD cases and 424,528 controls, LIPG N396S was associated with a CAD effect with an odds ratio of 0.90 (95% CI 0.86–0.95; P = 8.8 × 10–5) (38). Here, LIPG is linked to coronary artery disorder.